Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Dr Reddy’s pauses weight loss drug on quality fears
Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient manufacturing scale-up. The company assures that already supplied market products remain safe for patient use. Torrent Pharmaceuticals and USV Ltd are recalling some semaglutide batches sourced from Dr Reddy's. Commercial supplies are expected to resume after the issue is resolved and validation is complete.
Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice
Torrent Pharmaceuticals is voluntarily recalling select batches of its Semalix semaglutide injection pens. This action follows a product recall notification from its manufacturer, Dr. Reddy's Laboratories. Patient safety remains of paramount importance to the company during this process. There is no risk to patients currently using this specific treatment. All other Semaglutide products sold by Torrent remain unaffected.
Torrent Pharma among 6 stocks to hit 52-week highs & rally up to 25% in a month
Despite a sharp sell-off in the broader market, six BSE 200 stocks touched fresh 52-week highs, highlighting resilient investor confidence. The outperformers from retail, pharmaceuticals and energy sectors continued to show strong momentum, signalling sustained buying interest despite market volatility.
Torrent Pharmaceuticals Ltd spurts 0.67%, up for five straight sessions
Torrent Pharmaceuticals Ltd is quoting at Rs 4855.1, up 0.67% on the day as on 12:44 IST on the NSE. The stock is up 46.13% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% fall in the Nifty Pharma.
NCLT clears Torrent Pharma's merger with JB Chemicals
The National Company Law Tribunal (NCLT) has approved the merger of JB Chemicals & Pharmaceuticals with Torrent Pharmaceuticals. The amalgamation will take effect after the company files the tribunal's order with the Registrar of Companies.
Torrent Pharmaceuticals Ltd eases for fifth straight session
Torrent Pharmaceuticals Ltd is quoting at Rs 4426.6, down 0.36% on the day as on 13:19 IST on the NSE. The stock jumped 39.91% in last one year as compared to a 2.73% slide in NIFTY and a 12.63% spurt in the Nifty Pharma index.
Torrent Pharmaceuticals Ltd spurts 3.06%, rises for third straight session
Torrent Pharmaceuticals Ltd is quoting at Rs 4623.4, up 3.06% on the day as on 12:49 IST on the NSE. The stock is up 45.05% in last one year as compared to a 4.24% fall in NIFTY and a 14.46% fall in the Nifty Pharma index.
Torrent Pharmaceuticals consolidated net profit declines 26.91% in the March 2026 quarter
Sales rise 41.90% to Rs 4128.00 crore
Torrent Pharma Q4 net profit tanks despite jump in revenue; declares ₹9 dividend
Shares of Torrent Pharmaceuticals Ltd ended at ₹4,494.00, up by ₹23.15, or 0.52%, on the BSE.
Torrent Pharmaceuticals Ltd spurts 0.14%, up for five straight sessions
Torrent Pharmaceuticals Ltd is quoting at Rs 4369, up 0.14% on the day as on 12:44 IST on the NSE. The stock is up 39.09% in last one year as compared to a 0.65% gain in NIFTY and a 14.52% gain in the Nifty Pharma.
Torrent Pharmaceuticals Ltd up for third consecutive session
Torrent Pharmaceuticals Ltd is quoting at Rs 4341.6, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 31.92% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.
Zydus, Torrent Pharma join hands to co-market Semaglutide injection
Zydus Lifesciences and Torrent Pharmaceuticals have joined forces to bring a new diabetes and weight management medication to India. Zydus will manufacture the Semaglutide Injection, while Torrent Pharma will co-market it under its brand name Sembolic. This collaboration aims to leverage Torrent's strong presence in chronic therapies and its extensive field force across the country.